Revati Shreeniwas
President chez Revati, Inc.
Profil
Revati Shreeniwas is currently the President of Revati, Inc. and a Member of Continuing Medical Education, Inc. She previously worked as a Principal at Scios, Inc. and CV Therapeutics, Inc., as well as the Vice President of Clinical Research & Development at Alvine Pharmaceuticals, Inc. She also held the position of Principal at The Trustees of Columbia University in The City of New York and was a Professor at Stanford University.
Additionally, she served as the Chief Medical Officer at NeurAxon Pharma, Inc. from 2015 to 2017 and is currently the Chief Medical Officer at Bright Minds Biosciences, Inc. from 2020 to 2022.
Postes actifs de Revati Shreeniwas
| Sociétés | Poste | Début |
|---|---|---|
Continuing Medical Education, Inc.
 Continuing Medical Education, Inc. Publishing: Books/MagazinesConsumer Services Continuing Medical Education, Inc. is based in San Diego, CA. Part of The Nielsen Company (US) LLC, Continuing Medical Education, Inc. is a company that publishes medical magazines and journals. Continuing Medical Education was acquired by Miller Freeman, Inc., part of The Nielsen Company (US) LLC from July 18, 2000 on March 26, 1999 for $111 million. | Corporate Officer/Principal | - |
| Revati, Inc. | President | 01/01/2004 |
Anciens postes connus de Revati Shreeniwas
| Sociétés | Poste | Fin |
|---|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Directeur Technique/Scientifique/R&D | 01/12/2022 |
| SOLENO THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/06/2020 |
NeurAxon Pharma, Inc.
 NeurAxon Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon Pharma, Inc. researches and develops nervous system disorder therapies. The company is headquartered in Mississauga, Canada. | Directeur Technique/Scientifique/R&D | 01/01/2017 |
| Stanford University | Corporate Officer/Principal | - |
| The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SOLENO THERAPEUTICS, INC. | Health Technology |
| BRIGHT MINDS BIOSCIENCES INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Alvine Pharmaceuticals, Inc.
 Alvine Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Alvine Pharmaceuticals, Inc. develops and commercializes therapeutics for inflammatory diseases. It offers ALV003, tTG Inihibitors and HLA-DQ2 Blockers. The company was founded by Blair Stewart and Kevin R. Kaster in 2005 and is headquartered in San Carlos, CA. | Health Technology |
Continuing Medical Education, Inc.
Continuing Medical Education, Inc. Publishing: Books/MagazinesConsumer Services Continuing Medical Education, Inc. is based in San Diego, CA. Part of The Nielsen Company (US) LLC, Continuing Medical Education, Inc. is a company that publishes medical magazines and journals. Continuing Medical Education was acquired by Miller Freeman, Inc., part of The Nielsen Company (US) LLC from July 18, 2000 on March 26, 1999 for $111 million. | Consumer Services |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
| Revati, Inc. | |
NeurAxon Pharma, Inc.
NeurAxon Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon Pharma, Inc. researches and develops nervous system disorder therapies. The company is headquartered in Mississauga, Canada. | Commercial Services |
